Basics Spruce Biosciences, Inc. IPO Date: October 9, 2020 Sector: Healthcare Industry: Biotech Activated in VL: True Average Daily Range Avg Daily Range: $0.23 | 4.03% Avg Daily Range (30 D): $0.01 | 4.90% Avg Daily Range (90 D): $0.01 | 9.49% Institutional Daily Volume Avg Daily Volume: .51M Avg Daily Volume (30 D): .04M Avg Daily Volume (90 D): .41M Trade Size Avg Trade Size (Sh.): 301 Avg Trade Size (Sh.) (30 D): 1,239 Avg Trade Size (Sh.) (90 D): 2,427 Institutional Trades Total Inst.Trades: 46 Avg Inst. Trade: $1.79M Avg Inst. Trade (30 D): $.8M Avg Inst. Trade (90 D): $.8M Avg Inst. Trade Volume: .21M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.13M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 398.05K     News Jan 9, 2025 @ 6:00 PM Rare Endocrinology and Metabolic Disorders Market ... Source: Delveinsight May 13, 2024 @ 9:10 PM Spruce Biosciences, Inc. (SPRB) Reports Q1 Loss, T... Source: Zacks Equity Research May 1, 2024 @ 11:55 AM Pfizer (PFE) Q1 Earnings and Revenues Beat Estimat... Source: Zacks Equity Research Mar 27, 2024 @ 4:00 PM Spruce Biosciences (SPRB) Upgraded to Buy: Here's ... Source: Zacks Equity Research Mar 21, 2024 @ 2:20 PM Spruce Biosciences (SPRB) Falls 86% in a Month: He... Source: Zacks Equity Research Financials   TTM Q1 2025 Q4 2024 Basic EPS $-28.14 $-.32 $-.57 Diluted EPS $-28.14 $-.32 $-.57 Revenue $ 1.3M $ M $ .7M Gross Profit $ $ $ Net Income / Loss $ -48.34M $ -14.04M $ -23.56M Operating Income / Loss $ -50.67M $ -14.49M $ -24.07M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio